Fresenius reported €14.14B in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Akzo Nobel AKZA:NA € 5470M 601M
Alcon AG ALC:SW 2.25B 225M
AstraZeneca AZN:LN 22740M 146M
BASF BAS:GR € 25093M 5012M
Bayer BAYN:GR € 31019M 1616M
Davita Healthcare Partners DVA:US $ 2420.45M 21.91M
E.ON EOAN:GR 50.77B 10.26B
Fresenius FRE:GR € 14138M 924M
Fresenius Medical Care FMS:US $ 6377.45M 880.18M
Fresenius Medical Care FME:GR € 6377.45M 880.18M
Getinge GETIB:SS SK 7338M 3272M
Givaudan GIVN:VX 2.32B 96M
GlaxoSmithKline GSK:LN 24278M 608M
GN Store Nord GN:DC DK 8749M 2607M
GRIFOLS GRF:SM € 1921.48M 360.62M
Hikma Pharmaceutical HIK:LN 1.02B 56M
Lonza Group LONN:SW 2.37B 739M
Merck MRK:GR € 10207M 225M
Novartis NOVN:VX SF 29807M 401M
RWE RWE:GR € 138515M 41508M
William Demant Holding WDH:DC 10.97B 1.5B